Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Oramed Pharmaceuticals Inc., 3 years.
Oramed Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Dec 31, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +4,900 | — | — |
| Jun 5, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Jun 5, 2025 | Oramed Pharmaceuticals Inc. | Grant or award | +6,975 | — | — |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +9,325 | — | — |
| Apr 17, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Apr 4, 2023 | Oramed Pharmaceuticals Inc. | Open-market purchase | +3,800 | $2.21 | $8,398 |
| Apr 3, 2023 | Oramed Pharmaceuticals Inc. | Open-market purchase | +5,009 | $2.22 | $11,120 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.